세계의 엑소좀 진단 및 치료 시장

Global Exosome Diagnostic and Therapeutics Market to Reach US$2.8 Billion by 2030

The global market for Exosome Diagnostic and Therapeutics estimated at US$610.1 Million in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 29.2% over the analysis period 2024-2030. Instrument, one of the segments analyzed in the report, is expected to record a 31.4% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Reagent segment is estimated at 26.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$166.2 Million While China is Forecast to Grow at 38.5% CAGR

The Exosome Diagnostic and Therapeutics market in the U.S. is estimated at US$166.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$722.9 Million by the year 2030 trailing a CAGR of 38.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 23.3% and 26.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.7% CAGR.

Global Exosome Diagnostic and Therapeutics Market - Key Trends & Drivers Summarized

Why Are Exosomes Unlocking New Frontiers in Diagnostics and Precision Medicine?

Exosomes-small extracellular vesicles secreted by nearly all cell types-are emerging as revolutionary tools in the fields of diagnostics and therapeutics due to their unique ability to carry molecular information reflective of their cells of origin. These nano-sized vesicles contain proteins, lipids, and nucleic acids, making them ideal biomarkers for early detection of diseases such as cancer, neurodegenerative disorders, cardiovascular conditions, and infectious diseases. Their non-invasive availability in bodily fluids like blood, urine, and saliva enables liquid biopsies that are far safer and more convenient than traditional tissue biopsies. In oncology, exosomes are being investigated for real-time monitoring of tumor dynamics and treatment resistance, paving the way for more personalized and timely therapeutic decisions. Beyond diagnostics, exosomes are gaining momentum in drug delivery and regenerative medicine due to their inherent biocompatibility, low immunogenicity, and natural targeting capabilities. They can be engineered to deliver therapeutic molecules-including RNA therapeutics, proteins, and chemotherapeutic agents-directly to diseased cells, thus reducing off-target effects. The growing understanding of intercellular communication has positioned exosomes as a promising platform in precision medicine, where early intervention, real-time monitoring, and targeted therapies can dramatically improve patient outcomes. As research deepens, exosomes are no longer viewed as cellular debris but as key players in the future of healthcare.

How Are Innovations in Isolation and Characterization Accelerating Market Maturity?

The scalability and clinical translation of exosome-based diagnostics and therapeutics heavily depend on the precision and reproducibility of their isolation, purification, and characterization. Innovations in this area are driving the rapid maturation of the market. Traditional isolation methods such as ultracentrifugation are being supplemented or replaced by next-generation technologies like microfluidics, immunoaffinity capture, size-exclusion chromatography, and precipitation kits that offer higher purity, yield, and processing speed. These advances are enabling the development of commercial-grade exosome platforms that are suitable for clinical use. Similarly, breakthroughs in characterization techniques-including nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), flow cytometry, and surface plasmon resonance-are improving the standardization of exosome profiling, a crucial step in biomarker validation and therapeutic design. Bioinformatics and AI tools are also being used to decode the complex molecular signatures within exosomes, enabling identification of disease-specific biomarkers and patient stratification models. These technological improvements are attracting investments from pharmaceutical companies, biotech startups, and academic research institutions, all aiming to commercialize exosome-based solutions. Regulatory bodies are beginning to establish clearer pathways for clinical validation and approval, particularly for diagnostic applications, further supporting innovation. Collectively, these advancements are addressing one of the biggest historical bottlenecks in the exosome market-reliability of data and scalability of processes-thus accelerating clinical adoption and industrial growth.

What Therapeutic Applications Are Expanding the Market Beyond Oncology?

While oncology remains a primary focus for exosome research, the therapeutic applications of exosomes are rapidly expanding into new areas of medicine, broadening the scope and impact of the market. In neurology, exosomes have shown promise in delivering therapeutics across the blood-brain barrier-a major hurdle in treating diseases like Alzheimer’s, Parkinson’s, and glioblastoma. Their role in neuroinflammation modulation and neuronal regeneration is being actively explored. In cardiology, exosome-based therapies are being developed for myocardial infarction and ischemic injury, capitalizing on their regenerative potential and ability to modulate immune responses. In infectious disease, exosome diagnostics are being investigated for their ability to detect pathogens and monitor host immune responses, particularly in diseases with complex immunological signatures such as HIV and COVID-19. Autoimmune conditions, dermatological disorders, and even orthopedic applications are also seeing early-stage research into the use of exosomes for targeted therapy and tissue repair. In regenerative medicine, stem-cell-derived exosomes are being used in clinical trials to promote wound healing, cartilage regeneration, and anti-aging treatments. Additionally, interest is growing in combining exosome platforms with emerging modalities such as CRISPR gene editing, mRNA vaccines, and nanomedicine to create multifunctional therapeutic agents. These expanding use cases demonstrate that exosomes are not limited to a single disease class or clinical pathway-they offer a foundational technology platform that can be tailored to diverse therapeutic needs.

What Are the Key Factors Driving the Rapid Growth of the Exosome Diagnostics and Therapeutics Market?

The growth in the exosome diagnostic and therapeutics market is driven by several factors related to scientific advancement, unmet clinical needs, technological breakthroughs, and industry investment. One of the most significant drivers is the demand for non-invasive, early-stage diagnostic tools, especially for cancer and neurodegenerative diseases where traditional diagnostics are invasive, risky, or lack sensitivity. The rise of personalized medicine is also fueling the need for real-time biomarkers that can monitor disease progression and therapeutic response-capabilities for which exosomes are uniquely suited. Technological innovation in isolation, purification, and molecular profiling is making clinical translation more viable and scalable, reducing previous barriers to commercial application. On the therapeutic side, the growing need for targeted drug delivery systems that minimize systemic toxicity is enhancing the appeal of exosome-based delivery platforms. Increased funding from both public and private sectors, including large pharmaceutical companies investing in exosome R&D and biotech startups entering the space, is accelerating innovation pipelines. Additionally, the development of Good Manufacturing Practice (GMP)-compliant processes and advances in bioreactor technologies are enabling industrial-scale exosome production. Regulatory progress-though still evolving-is providing greater clarity for clinical trials and diagnostic approvals, particularly in the U.S., Europe, and parts of Asia. Rising healthcare expenditure, aging populations, and increased incidence of chronic diseases further underline the need for novel diagnostic and therapeutic solutions, positioning exosome technologies at the forefront of next-generation biomedical innovation. These combined forces are catalyzing rapid and sustained growth in the global exosome market.

SCOPE OF STUDY:

The report analyzes the Exosome Diagnostic and Therapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Instrument, Reagent, Software); Application (Diagnostic, Therapeutic); End-User (Cancer Institute, Hospitals, Diagnostic Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Aethlon Medical, Inc.
• AMSBIO
• Bio-Techne Corporation
• Capricor Therapeutics, Inc.
• Codiak Biosciences
• Evox Therapeutics Ltd.
• Exo Biologics
• ExoCoBio Inc.
• Exogenus Therapeutics
• Exosome Diagnostics, Inc.
• ILIAS Biologics Inc.
• INOVIQ Ltd.
• Izon Science Ltd.
• Kimera Labs
• Malvern Panalytical
• NanoFCM Inc.
• NanoSomiX, Inc.
• QIAGEN N.V.
• System Biosciences, LLC
• Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Exosome Diagnostic and Therapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Non-Invasive Biomarkers Propels Growth in Exosome-Based Diagnostic Solutions
  • Breakthroughs in Liquid Biopsy Technologies Throw the Spotlight on Exosomes as Precision Diagnostic Tools
  • Surging Investment in Personalized Medicine Expands the Addressable Market for Exosome Therapeutics
  • Advancements in Exosome Isolation and Characterization Strengthen the Business Case for Clinical Applications
  • Increased Focus on Early Cancer Detection Accelerates Demand for Exosome-Based Screening Platforms
  • Growing Research on Intercellular Communication Drives Innovation in Exosome-Derived Therapeutic Payloads
  • Pharmaceutical Interest in Drug Delivery Systems Spurs Development of Exosome-Based Nanocarriers
  • Expanding Applications in Neurological and Cardiovascular Disorders Propel Growth Beyond Oncology
  • Patient-Centric Diagnostics and Minimally Invasive Procedures Sustain Market Momentum in Exosome Technologies
  • Emerging Role of Exosomes in Immune Modulation Throws the Spotlight on Their Therapeutic Versatility
  • Technological Innovation in Microfluidics and High-Throughput Analysis Drives Adoption of Exosome Platforms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Exosome Diagnostic and Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Exosome Diagnostic and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Exosome Diagnostic and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Instrument by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Instrument by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Instrument by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Reagent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Cancer Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Cancer Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Cancer Institute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Exosome Diagnostic and Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Exosome Diagnostic and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Exosome Diagnostic and Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Exosome Diagnostic and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Exosome Diagnostic and Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Exosome Diagnostic and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Exosome Diagnostic and Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Exosome Diagnostic and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Exosome Diagnostic and Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Exosome Diagnostic and Therapeutics by Offering - Instrument, Reagent and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Exosome Diagnostic and Therapeutics by Offering - Percentage Breakdown of Value Sales for Instrument, Reagent and Software for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Exosome Diagnostic and Therapeutics by Application - Diagnostic and Therapeutic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Exosome Diagnostic and Therapeutics by Application - Percentage Breakdown of Value Sales for Diagnostic and Therapeutic for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Exosome Diagnostic and Therapeutics by End-user - Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Exosome Diagnostic and Therapeutics by End-user - Percentage Breakdown of Value Sales for Cancer Institute, Hospitals, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION